Clinical Trial Update: Treatment With Xeomin Versus Botox in Children With Spastic Equine and Equinovarus Foot Deformation in Pediatric Cerebral Palsy [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing Xeomin (incobotulinumtoxinA) to Botox (onabotulinumtoxinA) in children with cerebral palsy and spastic foot deformities has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Palsy

Drugs mentioned

• Botox (OnabotulinumtoxinA)
• XEOMIN (INCOBOTULINUMTOXINA)

Snippet

Sponsor: Merz Pharmaceuticals GmbH | Conditions: Cerebral Palsy, Spastic Paraplegia and Hemiparesis | Phase 2 | Status: COMPLETED